Abstract
This chapter examines the introductory elements in the report of a diagnostic test accuracy study. Central to this is the definition of the research question to be examined. An important distinction needs to be drawn between proof-of-concept or experimental studies, which are particularly appropriate for new diagnostic tests, and which may be undertaken in ideal or extreme contrast settings; and pragmatic studies which recruit consecutive patients and hence are more reflective of the idiom of day-to-day clinical practice.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdel-Aziz K, Larner AJ. Six-item Cognitive Impairment Test (6CIT): pragmatic diagnostic accuracy study for dementia and MCI. Int Psychogeriatr. 2015;27:in press.
Aji BM, Larner AJ. Screening for dementia: is one simple question the answer? Clin Med. 2015;15:111–2.
Alzheimer’s Society. Mapping the dementia gap: study produced by Tesco, Alzheimer’s Society and Alzheimer’s Scotland. London: Alzheimer’s Society; 2011.
Alzheimer’s Society. Mapping the dementia gap 2012. Progress on improving diagnosis of dementia 2011–2012. London: Alzheimer’s Society; 2013.
Alzheimer’s Society. Dementia UK (2nd edition – overview). London: Alzheimer’s Society; 2014.
Ames D, Burns A, O’Brien J, editors. Dementia (4th edition). London: Hodder Arnold; 2010.
Bateman RJ, Xiong C, Benzinger TL, et al. Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. N Engl J Med. 2012;367:795–804 [Erratum N Engl J Med. 2012;367:780].
Bossuyt PM, Reitsma JB, Bruns DE, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem. 2003;49:7–18.
Bresani CC, Braga MC, Felisberto DF, Tavares-de-Melo CE, Salvi DB, Batista-Filho M. Accuracy of erythrogram and serum ferritin for the maternal anemia diagnosis (AMA): a phase 3 diagnostic study on prediction of the therapeutic responsiveness to oral iron in pregnancy. BMC Pregnancy Childbirth. 2013;13:13.
Burch J, Marson A, Beyer F, et al. Dilemmas in the interpretation of diagnostic accuracy studies on presurgical workup for epilepsy surgery. Epilepsia. 2012;53:1294–302.
Cagliarini AM, Price HL, Livemore ST, Larner AJ. Will use of the Six-Item Cognitive Impairment Test help to close the dementia diagnosis gap? Aging Health. 2013;9:563–6.
Carnero-Pardo C, Espejo-Martinez B, Lopez-Alcalde S, et al. Diagnostic accuracy, effectiveness and cost for cognitive impairment and dementia screening of three short cognitive tests applicable to illiterates. PLoS One. 2011;6(11):e27069.
Cordell CB, Borson S, Boustani M, et al. Alzheimer’s Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting. Alzheimers Dement. 2013;9:141–50.
Crombie IK. The pocket guide to critical appraisal. London: BMJ Books; 1996.
Croskerry P. From mindless to mindful practice – cognitive bias and clinical decision making. N Engl J Med. 2013;368:2445–8.
Department of Health. Living well with dementia: a National Dementia Strategy. London: Department of Health; 2009.
Department of Health. Prime Minister’s challenge on dementia. Delivering major improvements in dementia care and research by 2015. London: Department of Health; 2012a.
Department of Health. Using the Commissioning for Quality and Innovation (CQUIN) payment framework. Guidance on the new national goals 2012–13. London: Department of Health; 2012b.
Dickerson B, Atri A. Dementia. Comprehensive principles and practice. Oxford: Oxford University Press; 2014.
Doran M, Vinjamuri S, Collins J, Parker D, Larner AJ. SPECT perfusion imaging in the differential diagnosis of dementia: a retrospective regional audit. Int J Clin Pract. 2005;59:496–500.
Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6:734–46.
Dubois B, Feldman HH, Jacova C, et al. Revising the definition of Alzheimer’s disease: a new lexicon. Lancet Neurol. 2010;9:1118–27.
Dubois B, Feldman HH, Jacova C, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol. 2014;13:614–29 [Erratum Lancet Neurol. 2014;13:757].
Ferrante di Ruffano L, Hyde CJ, McCaffery KJ, Bossuyt PM, Deeks JJ. Assessing the value of diagnostic tests: a framework for designing and evaluating trials. BMJ. 2012;344:e686.
Fox C, Lafortune L, Boustani M, Dening T, Rait G, Brayne C. Screening for dementia – is it a no brainer? Int J Clin Pract. 2013;67:1076–80.
Fryback DG, Thornbury JR. The efficacy of diagnostic imaging. Med Decis Making. 1991;11:88–94.
Ghadiri-Sani M, Larner AJ. How to write a case report. Br J Hosp Med. 2014a;75:207–10.
Ghadiri-Sani M, Larner AJ. Cognitive screening instrument use in primary care: is it changing? Clin Pract. 2014b;11:425–9.
Gifford DR, Cummings JL. Evaluating dementia screening tests. Methodologic standards to rate their performance. Neurology. 1999;52:224–7.
Gluud C, Gluud LL. Evidence based diagnosis. BMJ. 2005;330:724–6.
Hancock P, Larner AJ. The diagnosis of dementia: diagnostic accuracy of an instrument measuring activities of daily living in a clinic-based population. Dement Geriatr Cogn Disord. 2007;23:133–9.
Hancock P, Larner AJ. Cambridge Behavioural Inventory for the diagnosis of dementia. Prog Neurol Psychiatry. 2008;12(7):23–5.
Hancock P, Larner AJ. Diagnostic utility of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) and its combination with the Addenbrooke’s Cognitive Examination-Revised (ACE-R) in a memory clinic-based population. Int Psychogeriatr. 2009a;21:526–30.
Hancock P, Larner AJ. Clinical utility of Patient Health Questionnaire-9 (PHQ-9) in memory clinics. Int J Psychiatry Clin Pract. 2009b;13:188–91.
Hancock P, Larner AJ. Diagnostic utility of the Pittsburgh Sleep Quality Index in memory clinics. Int J Geriatr Psychiatry. 2009c;24:1237–41.
Hancock P, Larner AJ. Test Your Memory (TYM) test: diagnostic utility in a memory clinic population. Int J Geriatr Psychiatry. 2011;26:976–80.
Jack Jr CR, Knopman DS, Jagust WJ, et al. Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12:207–16.
Kapur N, Pearson D. Memory symptoms and memory performance of neurological patients. Br J Psychol. 1983;74:409–15.
Knottnerus JA, Muris JW. Assessment of the accuracy of diagnostic tests: the cross-sectional study. In: Knottnerus JA, editor. The evidence base of clinical diagnosis. London: BMJ Books; 2002. p. 39–59.
Knottnerus JA, van Weel C. General introduction: evaluation of diagnostic procedures. In: Knottnerus JA, editor. The evidence base of clinical diagnosis. London: BMJ Books; 2002. p. 1–17.
Kurlan R, editor. Handbook of secondary dementias. New York: Taylor and Francis; 2006.
Larner AJ. An audit of the Addenbrooke’s Cognitive Examination (ACE) in clinical practice. Int J Geriatr Psychiatry. 2005;20:593–4.
Larner AJ. An audit of the Addenbrooke’s Cognitive Examination (ACE) in clinical practice. 2. Longitudinal change. Int J Geriatr Psychiatry. 2006a;21:698–9.
Larner AJ. Proton magnetic resonance spectroscopy (1H-MRS): audit of pragmatic use in the Cognitive Function Clinic. J Neurol. 2006b;253 Suppl 2:II92 (abstract P363).
Larner AJ. DemTect: 1-year experience of a neuropsychological screening test for dementia. Age Ageing. 2007a;36:326–7.
Larner AJ. Addenbrooke’s Cognitive Examination (ACE) for the diagnosis and differential diagnosis of dementia. Clin Neurol Neurosurg. 2007b;109:491–4.
Larner AJ. Addenbrooke’s Cognitive Examination-Revised (ACE-R) in day-to-day clinical practice. Age Ageing. 2007c;36:685–6.
Larner AJ. Impact of the National Dementia Strategy in a neurology-led memory clinic. Clin Med. 2010a;10:526.
Larner AJ. Can IQCODE differentiate Alzheimer’s disease and frontotemporal dementia? Age Ageing. 2010b;39:392–4.
Larner AJ. Audit of practice versus guidelines: neuro-imaging in a dementia clinic. Morecambe Bay Med J. 2011;6:110–2.
Larner AJ. Pragmatic diagnostic accuracy studies. http://bmj.com/content/345/bmj.e3999?tab=responses, 28 Aug 2012a.
Larner AJ. Screening utility of the Montreal Cognitive Assessment (MoCA): in place of - or as well as - the MMSE? Int Psychogeriatr. 2012b;24:391–6.
Larner AJ. Mini-Mental Parkinson (MMP) as a dementia screening test: comparison with the Mini-Mental State Examination (MMSE). Curr Aging Sci. 2012c;5:136–9.
Larner AJ. Head turning sign: pragmatic utility in clinical diagnosis of cognitive impairment. J Neurol Neurosurg Psychiatry. 2012d;83:852–3.
Larner AJ. Can the informant Fluctuation Composite Score help in the diagnosis of synucleinopathies? A pragmatic study. Int J Geriatr Psychiatry. 2012e;27:1094–5.
Larner AJ. Neuropsychological neurology: the neurocognitive impairments of neurological disorders (2nd edition). Cambridge: Cambridge University Press; 2013a.
Larner AJ. Introduction to cognitive screening instruments: rationale, desiderata, and assessment of utility. In: Larner AJ, editor. Cognitive screening instruments. A practical approach. London: Springer; 2013b. p. 1–14.
Larner AJ. Subjective memory complaints: is family history of dementia a risk factor? J Neurol Sci. 2013c;333:e295.
Larner AJ. Codex (cognitive disorders examination) for the detection of dementia and mild cognitive impairment. Codex pour la détection de la démence et du mild cognitive impairment. Presse Med. 2013d;42:e425–8.
Larner AJ. Can the Frontal Assessment Battery (FAB) help in the diagnosis of behavioural variant frontotemporal dementia? A pragmatic study. Int J Geriatr Psychiatry. 2013e;28:106–7.
Larner AJ. Addenbrooke’s Cognitive Examination-Revised (ACE-R): pragmatic study of cross-sectional use for assessment of cognitive complaints of unknown aetiology. Int J Geriatr Psychiatry. 2013f;28:547–8.
Larner AJ. Dementia in clinical practice: a neurological perspective. Pragmatic studies in the cognitive function clinic (2nd edition). London: Springer; 2014a.
Larner AJ. Screening utility of the “attended alone” sign for subjective memory impairment. Alzheimer Dis Assoc Disord. 2014b;28:364–5.
Larner AJ. Impact of the National Dementia Strategy in a neurology-led memory clinic: 5-year data. Clin Med. 2014c;14:216.
Larner AJ. Effect size (Cohen’s d) of cognitive screening instruments examined in pragmatic diagnostic accuracy studies. Dement Geriatr Cogn Disord Extra. 2014d;4:236–41.
Larner AJ. AD8 informant questionnaire for cognitive impairment: pragmatic diagnostic test accuracy study. J Geriatr Psychiatry Neurol. 2015a;28:in press.
Larner AJ. Optimizing the cutoffs of cognitive screening instruments in pragmatic diagnostic accuracy studies: maximising accuracy or Youden index? Dement Geriatr Cogn Disord. 2015b;39:167–75.
Larner AJ. Hard-TYM: a pragmatic study. Int J Geriatr Psychiatry. 2015c;30:330–1.
Larner AJ. Mini-Addenbrooke’s Cognitive Examination: a pragmatic diagnostic accuracy study. Int J Geriatr Psychiatry. 2015d;30:in press.
Larner AJ, Marson AG. Epileptic seizures in Alzheimer’s disease: another fine MESS? J Alzheimers Dis. 2011;25:417–9.
Larner AJ, Coles AJ, Scolding NJ, Barker RA. The A-Z of neurological practice. A guide to clinical neurology (2nd edition). London: Springer; 2011.
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
Lijmer JG, Leeflang M, Bossuyt PM. Proposals for a phased evaluation of medical tests. Med Decis Making. 2009;29:E13–21.
Marson A, Jacoby A, Johnson A, et al. Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet. 2005;365:2007–12.
McKeith I, O’Brien J, Walker Z, et al. Sensitivity and specificity of dopamine transporter imaging with123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol. 2007;6:305–13.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease. Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Service Task forces on Alzheimer’s disease. Neurology. 1984;34:939–44.
McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:263–9.
Mendez MF, Cummings JL. Dementia: a clinical approach (3rd edition). Philadelphia: Butterworth-Heinemann; 2003.
Menon R, Larner AJ. Use of cognitive screening instruments in primary care: the impact of national dementia directives (NICE/SCIE, National Dementia Strategy). Fam Pract. 2011;28:272–6.
Mills JK, Minhas JS, Robotham SL. An assessment of the dementia CQUIN – an audit of improving compliance. Dementia (London). 2014;13:697–703.
Mitchell AJ, Beaumont H, Ferguson D, Yadegarfar M, Stubbs B. Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis. Acta Psychiatr Scand. 2014;130:439–51.
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
Montori VM, Wyer P, Newman TB, et al. Tips for learners of evidence-based medicine: 5. The effect of spectrum of disease on the performance of diagnostic tests. CMAJ. 2005;173:385–90.
National Institute for Clinical Excellence. Principles for best practice in clinical audit. Abingdon: Radcliffe Medical Press; 2002.
Noel-Storr AH, McCleery JM, Richard E, et al. Reporting standards for studies of diagnostic test accuracy in dementia: the STARDdem Initiative. Neurology. 2014;83:364–73.
Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer’s disease: an analysis of population-based data. Lancet Neurol. 2014;13:788–94.
Ochodo EA, Bossuyt PM. Reporting the accuracy of diagnostic tests: the STARD Initiative 10 years on. Clin Chem. 2013;59:917–9.
Prince M, Bryce R, Ferri C. World Alzheimer Report 2011. The benefits of early diagnosis and intervention. London: Alzheimer’s Disease International; 2011.
Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013;9:63–75.e2.
Quinn JF, editor. Dementia. Chichester: Wiley; 2014.
Ransohoff DF, Feinstein AR. Problems of spectrum bias in evaluating the efficacy of diagnostic tests. N Engl J Med. 1978;299:926–30.
Richard E, Schmand BA, Eikelenboom P, Van Gool WA. The Alzheimer’s Disease Neuroimaging Initiative. MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer’s disease in patients with mild cognitive impairment: a diagnostic accuracy study. BMJ Open. 2013;3:e002541.
Rifai N, Altman DG, Bossuyt PM. Reporting bias in diagnostic and prognostic studies: time for action. Clin Chem. 2008;54:1101–3.
Rutjes AW, Reitsma JB, Di Nisio M, Smidt N, van Rijn JC, Bossuyt PM. Evidence of bias and variation in diagnostic accuracy studies. CMAJ. 2006;174:469–76.
Sackett DL, Haynes RB. The architecture of diagnostic research. In: Knottnerus JA, editor. The evidence base of clinical diagnosis. London: BMJ Books; 2002a. p. 19–38.
Sackett DL, Haynes RB. The architecture of diagnostic research. BMJ. 2002b;324:539–41.
Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408–12.
Scottish Intercollegiate Guidelines Network. Methodology checklist 5: studies of diagnostic accuracy. In: A guideline developer’s handbook. Edinburgh: SIGN; 2007. Annex B.
Sells R, Larner AJ. The Poppelreuter figure visual perceptual function test for dementia diagnosis. Prog Neurol Psychiatry. 2011;15(2):17–8, 20–21.
Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349:g7647.
Sundar S, Singh RK, Bimal SK, et al. Comparative evaluation of parasitology and serological tests in the diagnosis of visceral leishmaniasis in India: a phase III diagnostic accuracy study. Trop Med Int Health. 2007;12:284–9.
Tatsioni A, Zarin DA, Aronson N, et al. Challenges in systematic reviews of diagnostic technologies. Ann Intern Med. 2005;142:1048–55.
Thomas M. We are not ourselves. London: Fourth Estate; 2014.
Tricco AC, Soobiah C, Berliner S, et al. Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysis. CMAJ. 2013;185:1393–401.
van der Linde RM, Stephan BCM, Dening T, Brayne C. Instruments to measure behavioural and psychological symptoms of dementia. Int J Methods Psychiatr Res. 2014;23:69–98.
Whiting P, Rutjes AW, Dinnes J, Reitsma J, Bossuyt PM, Kleijnen J. Development and validation of methods for assessing the quality of diagnostic accuracy studies. Health Technol Assess. 2004;8:iii, 1–234.
Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529–36.
Wilson JMG, Jungner G. Principles and practice of screening for disease, Public health paper No. 34. Geneva: World Health Organization; 1968.
Wimo A, Prince M. World Alzheimer Report 2010. The global economic impact of dementia. London: Alzheimer’s Disease International; 2010.
World Health Organization. Dementia: a public health priority. Geneva: World Health Organization; 2012.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Larner, A.J. (2015). Introduction. In: Diagnostic Test Accuracy Studies in Dementia. Springer, Cham. https://doi.org/10.1007/978-3-319-16697-1_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-16697-1_1
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-16696-4
Online ISBN: 978-3-319-16697-1
eBook Packages: MedicineMedicine (R0)